ONXX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Onyx Pharmaceuticals, Inc.'s quarterly cash and cash equivalents increased from Dec. 2012 ($153.2 Mil) to Mar. 2013 ($436.5 Mil) but then declined from Mar. 2013 ($436.5 Mil) to Jun. 2013 ($323.1 Mil).
Onyx Pharmaceuticals, Inc.'s annual cash and cash equivalents declined from Dec. 2010 ($226.3 Mil) to Dec. 2011 ($171.6 Mil) and declined from Dec. 2011 ($171.6 Mil) to Dec. 2012 ($153.2 Mil).
Cash and cash equivalents on banks book.
* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.
Onyx Pharmaceuticals, Inc. Annual Data
Onyx Pharmaceuticals, Inc. Quarterly Data